Pediatrics content commonly referenced by physicians includes clinical practice guidelines, therapeutic advances, clinical trials, and validated clinical decision tools. The following 10-item framework reflects widely used resources that inform pediatric care.

1. Bright Futures/American Academy of Pediatrics (AAP) Recommendations for Preventive Pediatric Health Care — The Bright Futures guidelines provide recommendations for preventive health supervision of infants, children, and adolescents. The accompanying Bright Futures/AAP Periodicity Schedule outlines age-based preventive health supervision visits and includes recommended screenings, assessments, physical examinations, procedures, and anticipatory guidance.

2. AAP Clinical Practice Guideline for Childhood Obesity — The AAP guideline provides evidence-based recommendations for the evaluation and treatment of pediatric patients with overweight and obesity. The guidance addresses evaluation, intensive health behavior and lifestyle treatment, pharmacotherapy, and metabolic and bariatric surgery for eligible patients.

3. AAP Clinical Practice Guideline for Febrile Infants — The AAP guideline provides recommendations for the evaluation and management of well-appearing, term infants aged 8 to 60 days with fever. The guidance includes age-based recommendations for diagnostic testing, antimicrobial therapy, hospitalization, outpatient management, and shared decision-making with parents.

4. AAP Clinical Practice Guideline for Hyperbilirubinemia — The AAP guideline provides recommendations for the management of hyperbilirubinemia in newborn infants born at 35 or more weeks’ gestation. The guidance addresses prevention, risk assessment, bilirubin monitoring, treatment, follow-up, phototherapy, and exchange transfusion.

5. MELODY Trial — The phase 3 MELODY trial evaluated a single dose of nirsevimab in healthy late-preterm and term infants before the start of a respiratory syncytial virus (RSV) season. Compared with placebo, nirsevimab reduced medically attended RSV-associated lower respiratory tract infections through 150 days following administration.

6. STEP TEENS Trial — The phase 3a STEP TEENS trial evaluated once-weekly semaglutide plus lifestyle intervention in adolescents with obesity or with overweight and at least 1 weight-related condition. Compared with placebo plus lifestyle intervention, semaglutide was associated with greater reductions in body mass index at 68 weeks.

7. Nirsevimab for RSV Prevention — The Centers for Disease Control and Prevention recommends either maternal RSV vaccination during pregnancy or infant immunization with a long-acting monoclonal antibody to help prevent severe RSV disease in infants. The guidance states that most infants do not need both maternal vaccination and infant RSV antibodies.

8. National Asthma Education and Prevention Program Asthma Management Guidelines — The 2020 National Asthma Education and Prevention Program report revised selected portions of the 2007 asthma management guidelines in 6 areas. The updates address intermittent inhaled corticosteroids, long-acting muscarinic antagonists, bronchial thermoplasty, immunotherapy, indoor allergen mitigation, and fractional exhaled nitric oxide.

9. Pediatric Emergency Care Applied Research Network Head Trauma Rule — The Pediatric Emergency Care Applied Research Network developed and validated age-specific clinical prediction rules to identify pediatric patients at very low risk of clinically important traumatic brain injury following head trauma. The rules help identify children for whom computed tomography imaging may be unnecessary.

10. Centers for Disease Control and Prevention Child and Adolescent Immunization Schedule (2025) — The Centers for Disease Control and Prevention Child and Adolescent Immunization Schedule contains recommendations for patients from birth through age 18 years. The schedule helps health care providers determine recommended vaccines by age, catch-up vaccination intervals, additional vaccines based on medical conditions or other indications, special situations, and contraindications and precautions.

Sources: American Academy of Pediatrics, Bright Futures, National Heart, Lung, and Blood Institute, Centers for Disease Control and Prevention, The New England Journal of Medicine, Pediatric Emergency Care Applied Research Network, The Lancet